Robert Whitfield MDAmerica's Breast Implant Illness Expert™

BIA-ALCL: What Reports About Smooth and Textured Implants Show

1 Oct 2026 · 1 min

Watch on YouTube

0:30

In this segment, Dr. Robert Whitfield reviews FDA medical device reports concerning breast implants and the risk of Breast Implant‑Associated Anaplastic Large Cell Lymphoma (BIA‑ALCL). He points out that only a small number of reports involve smooth‑surface implants, and many of those lack complete patient histories or do not clarify whether the patients previously had textured devices. Because of these gaps, the data cannot be taken as evidence that smooth implants carry the same BIA‑ALCL risk as textured ones. Dr. Whitfield emphasizes that the safety signal is overwhelmingly linked to textured surfaces, with the strongest signal observed for the most aggressively textured implants.

Now, the FDA's medical device reports include a small number of smooth implant cases, but most of those reports had incomplete histories, or they didn't know if they had prior textured devices, or the texture was unknown. So incomplete records are not the same as proof that smooth implants carry the same risk. The honest summary is this: the signal is overwhelmingly associated with textured surfaces, and the highest signal has been with more aggressively textured devices.